PRKN and ovarian cancer: The mitochondrial autophagy-associated PINK1/parkin pathway, BNIP3 molecules, and mitochondrial Ca2+ absorption promotion in the MAM might all be used to manipulate ovarian cancer cell metastasis and drug resistance (68, 70, 71).